hBMSC-EVs alleviate weightlessness-induced skeletal muscle atrophy by suppressing oxidative stress and inflammation

Abstract Background Muscle disuse and offloading in microgravity are likely the primary factors mediating spaceflight-induced muscle atrophy, for which there is currently no effective treatment other than exercise. Extracellular vesicles derived from bone marrow mesenchymal stem cells (BMSC-EVs) pos...

Full description

Saved in:
Bibliographic Details
Main Authors: Mengyuan Chang, Ruiqi Liu, Bingqian Chen, Jin Xu, Wei Wang, Yanan Ji, Zihui Gao, Boya Liu, Xinlei Yao, Hualin Sun, Feng Xu, Yuntian Shen
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13287-025-04175-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825197558299885568
author Mengyuan Chang
Ruiqi Liu
Bingqian Chen
Jin Xu
Wei Wang
Yanan Ji
Zihui Gao
Boya Liu
Xinlei Yao
Hualin Sun
Feng Xu
Yuntian Shen
author_facet Mengyuan Chang
Ruiqi Liu
Bingqian Chen
Jin Xu
Wei Wang
Yanan Ji
Zihui Gao
Boya Liu
Xinlei Yao
Hualin Sun
Feng Xu
Yuntian Shen
author_sort Mengyuan Chang
collection DOAJ
description Abstract Background Muscle disuse and offloading in microgravity are likely the primary factors mediating spaceflight-induced muscle atrophy, for which there is currently no effective treatment other than exercise. Extracellular vesicles derived from bone marrow mesenchymal stem cells (BMSC-EVs) possess anti-inflammatory and antioxidant properties, offering a potential strategy for combating weightless muscular atrophy. Methods In this study, human BMSCs-EVs (hBMSC-EVs) were isolated using super-centrifugation and characterized. C2C12 myotube nutrition-deprivation and mice tail suspension models were established. Subsequently, the diameter of C2C12 myotubes, Soleus mass, cross-sectional area (CSA) of muscle fibers, and grip strength in mice were assessed to investigate the impact of hBMSC-EVs on muscle atrophy. Immunostaining, transmission electron microscopy observation, and western blot analysis were employed to assess the impact of hBMSC-EVs on muscle fiber types, ROS levels, inflammation, ubiquitin–proteasome system activity, and autophagy lysosome pathway activation in skeletal muscle atrophy. Results The active hBMSC-EVs can be internalized by C2C12 myotubes and skeletal muscle. hBMSC-EVs can effectively reduce C2C12 myotube atrophy caused by nutritional deprivation, with a concentration of 10 × 108 particles/mL showing the best effect (P < 0.001). Additionally, hBMSC-EVs can down-regulate the protein levels associated with UPS and oxidative stress. Moreover, intravenous administration of hBMSC-EVs at a concentration of 1 × 1010 particles/mL can effectively reverse the reduction in soleus mass (P < 0.001), CSA (P < 0.01), and grip strength (P < 0.001) in mice caused by weightlessness. They demonstrate the ability to inhibit protein degradation mediated by UPS and autophagy lysosome pathway, along with the suppression of oxidative stress and inflammatory responses. Furthermore, hBMSC-EVs impede the transition of slow muscle fibers to fast muscle fibers via upregulation of Sirt1 and PGC-1α protein levels. Conclusions Our findings indicate that hBMSC-EVs are capable of inhibiting excessive activation of the UPS and autophagy lysosome pathway, suppressing oxidative stress and inflammatory response, reversing muscle fiber type transformation, effectively delaying hindlimb unloading-induced muscle atrophy and enhancing muscle function. Our study has further advanced the understanding of the molecular mechanism underlying muscle atrophy in weightlessness and has demonstrated the protective effect of hBMSC-EVs on muscle atrophy.
format Article
id doaj-art-081685a12dd344388c420ed4399c82b1
institution Kabale University
issn 1757-6512
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj-art-081685a12dd344388c420ed4399c82b12025-02-09T12:15:32ZengBMCStem Cell Research & Therapy1757-65122025-02-0116111810.1186/s13287-025-04175-yhBMSC-EVs alleviate weightlessness-induced skeletal muscle atrophy by suppressing oxidative stress and inflammationMengyuan Chang0Ruiqi Liu1Bingqian Chen2Jin Xu3Wei Wang4Yanan Ji5Zihui Gao6Boya Liu7Xinlei Yao8Hualin Sun9Feng Xu10Yuntian Shen11Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong UniversityDepartment of Clinical Medicine, Medical College, Nantong UniversityDepartment of Orthopedics, First People’s Hospital of Changshu City, Changshu Hospital Affiliated to Soochow UniversityDepartment of Basic Medicine, Kangda College of Nanjing Medical UniversityKey Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong UniversityKey Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong UniversityKey Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong UniversityKey Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong UniversityKey Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong UniversityKey Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong UniversityDepartment of Endocrinology, Affiliated Hospital 2 of Nantong University and First People’s Hospital of Nantong CityKey Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong UniversityAbstract Background Muscle disuse and offloading in microgravity are likely the primary factors mediating spaceflight-induced muscle atrophy, for which there is currently no effective treatment other than exercise. Extracellular vesicles derived from bone marrow mesenchymal stem cells (BMSC-EVs) possess anti-inflammatory and antioxidant properties, offering a potential strategy for combating weightless muscular atrophy. Methods In this study, human BMSCs-EVs (hBMSC-EVs) were isolated using super-centrifugation and characterized. C2C12 myotube nutrition-deprivation and mice tail suspension models were established. Subsequently, the diameter of C2C12 myotubes, Soleus mass, cross-sectional area (CSA) of muscle fibers, and grip strength in mice were assessed to investigate the impact of hBMSC-EVs on muscle atrophy. Immunostaining, transmission electron microscopy observation, and western blot analysis were employed to assess the impact of hBMSC-EVs on muscle fiber types, ROS levels, inflammation, ubiquitin–proteasome system activity, and autophagy lysosome pathway activation in skeletal muscle atrophy. Results The active hBMSC-EVs can be internalized by C2C12 myotubes and skeletal muscle. hBMSC-EVs can effectively reduce C2C12 myotube atrophy caused by nutritional deprivation, with a concentration of 10 × 108 particles/mL showing the best effect (P < 0.001). Additionally, hBMSC-EVs can down-regulate the protein levels associated with UPS and oxidative stress. Moreover, intravenous administration of hBMSC-EVs at a concentration of 1 × 1010 particles/mL can effectively reverse the reduction in soleus mass (P < 0.001), CSA (P < 0.01), and grip strength (P < 0.001) in mice caused by weightlessness. They demonstrate the ability to inhibit protein degradation mediated by UPS and autophagy lysosome pathway, along with the suppression of oxidative stress and inflammatory responses. Furthermore, hBMSC-EVs impede the transition of slow muscle fibers to fast muscle fibers via upregulation of Sirt1 and PGC-1α protein levels. Conclusions Our findings indicate that hBMSC-EVs are capable of inhibiting excessive activation of the UPS and autophagy lysosome pathway, suppressing oxidative stress and inflammatory response, reversing muscle fiber type transformation, effectively delaying hindlimb unloading-induced muscle atrophy and enhancing muscle function. Our study has further advanced the understanding of the molecular mechanism underlying muscle atrophy in weightlessness and has demonstrated the protective effect of hBMSC-EVs on muscle atrophy.https://doi.org/10.1186/s13287-025-04175-yBone marrow mesenchymal stem cellsExtracellular vesiclesMuscle atrophyOxidative stressInflammation
spellingShingle Mengyuan Chang
Ruiqi Liu
Bingqian Chen
Jin Xu
Wei Wang
Yanan Ji
Zihui Gao
Boya Liu
Xinlei Yao
Hualin Sun
Feng Xu
Yuntian Shen
hBMSC-EVs alleviate weightlessness-induced skeletal muscle atrophy by suppressing oxidative stress and inflammation
Stem Cell Research & Therapy
Bone marrow mesenchymal stem cells
Extracellular vesicles
Muscle atrophy
Oxidative stress
Inflammation
title hBMSC-EVs alleviate weightlessness-induced skeletal muscle atrophy by suppressing oxidative stress and inflammation
title_full hBMSC-EVs alleviate weightlessness-induced skeletal muscle atrophy by suppressing oxidative stress and inflammation
title_fullStr hBMSC-EVs alleviate weightlessness-induced skeletal muscle atrophy by suppressing oxidative stress and inflammation
title_full_unstemmed hBMSC-EVs alleviate weightlessness-induced skeletal muscle atrophy by suppressing oxidative stress and inflammation
title_short hBMSC-EVs alleviate weightlessness-induced skeletal muscle atrophy by suppressing oxidative stress and inflammation
title_sort hbmsc evs alleviate weightlessness induced skeletal muscle atrophy by suppressing oxidative stress and inflammation
topic Bone marrow mesenchymal stem cells
Extracellular vesicles
Muscle atrophy
Oxidative stress
Inflammation
url https://doi.org/10.1186/s13287-025-04175-y
work_keys_str_mv AT mengyuanchang hbmscevsalleviateweightlessnessinducedskeletalmuscleatrophybysuppressingoxidativestressandinflammation
AT ruiqiliu hbmscevsalleviateweightlessnessinducedskeletalmuscleatrophybysuppressingoxidativestressandinflammation
AT bingqianchen hbmscevsalleviateweightlessnessinducedskeletalmuscleatrophybysuppressingoxidativestressandinflammation
AT jinxu hbmscevsalleviateweightlessnessinducedskeletalmuscleatrophybysuppressingoxidativestressandinflammation
AT weiwang hbmscevsalleviateweightlessnessinducedskeletalmuscleatrophybysuppressingoxidativestressandinflammation
AT yananji hbmscevsalleviateweightlessnessinducedskeletalmuscleatrophybysuppressingoxidativestressandinflammation
AT zihuigao hbmscevsalleviateweightlessnessinducedskeletalmuscleatrophybysuppressingoxidativestressandinflammation
AT boyaliu hbmscevsalleviateweightlessnessinducedskeletalmuscleatrophybysuppressingoxidativestressandinflammation
AT xinleiyao hbmscevsalleviateweightlessnessinducedskeletalmuscleatrophybysuppressingoxidativestressandinflammation
AT hualinsun hbmscevsalleviateweightlessnessinducedskeletalmuscleatrophybysuppressingoxidativestressandinflammation
AT fengxu hbmscevsalleviateweightlessnessinducedskeletalmuscleatrophybysuppressingoxidativestressandinflammation
AT yuntianshen hbmscevsalleviateweightlessnessinducedskeletalmuscleatrophybysuppressingoxidativestressandinflammation